3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other
1
Genitourinary
1
Conditions
Motor Activity
4
Prostatic Neoplasms
3
Malnutrition
3
Stomach Neoplasms
2
Frailty
2
Breast Neoplasms
2
Urologic Neoplasms
1
Smoking
1
Risk Reduction Behavior
1
Postoperative Complications
1
Patient Preference
1
Obesity
1
Neoplasms
1
Hematologic Neoplasms
1
Fatigue
1
Esophageal Squamous Cell Carcinoma
1
Esophageal Neoplasms
1
Depression
1
Carcinoma, Non-Small-Cell Lung
1
Breast Neoplasms, Male
1
Alcohol Drinking
1
Interventions
Exercise
24
Metformin
19
Tirzepatide
9
Resistance Training
8
Nutrition Assessment
8
Methods
8
Diet Therapy
8
Diet
8
Counseling
7
Surveys and Questionnaires
6
semaglutide
5
Liraglutide
5
Exenatide
5
Early Intervention, Educational
5
Diet, Mediterranean
5
Caloric Restriction
5
Blood Specimen Collection
5
Educational Status
4
Bariatric Surgery
4
Vitamin D
3
Sugars
3
Standard of Care
3
Naltrexone
3
Letrozole
3
Docosahexaenoic Acids
3
Dexamethasone
3
Bupropion
3
exemestane
2
bupropion hydrochloride, naltrexone hydrochoride drug combination
2
Yoga
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Obesity
×
Nutritional Support
×
Clear all
NCT04088968
2024-03-22
STRONG-CS
Bispebjerg Hospital
Phase NA
Unknown
100 enrolled